When you look at the economic landscape of the Midwest, one sector stands out for its sheer scale and momentum. The healthcare and life sciences industry across Limerick, Clare, and Tipperary has quietly evolved into a globally significant ecosystem. Today, our region hosts 153 multinational companies and employs over 27,000 people. This represents a massive shift in how we do business, create jobs, and build our local communities.
As a member of the Limerick Chamber, you already know our region is growing. But understanding the specific dynamics of this high-value sector can help you identify real-world opportunities for your own organisation. Even if you do not operate directly in healthcare or pharmaceuticals, the ripple effects of this industry touch every part of our local economy, from logistics and construction to human resources and professional services.
This post will guide you through the core strengths of our regional life sciences sector. We will explore the distinct advantages of our neighbouring counties, the infrastructure supporting this growth, and the practical steps your business can take to integrate into this thriving supply chain.
A region built on distinct strengths
The Midwest benefits from a highly resilient, diversified industrial base. Rather than competing, our counties have developed distinct specialisations that complement one another perfectly. This collaborative environment offers a robust foundation for businesses looking to expand their services across the region.
Limerick: The biologics and MedTech engine
Limerick serves as the industrial engine for the entire region, anchored by large-scale biologics and medical technology (MedTech) manufacturing. The scale of investment here is truly remarkable. Regeneron operates the largest biologics production site in Ireland out of Raheen, employing over 1,000 people following a €1 billion investment.
Eli Lilly is currently expanding this local footprint with a €2 billion “digital-first” biologic facility, which will begin production in 2026. Alongside these pharmaceutical giants, major MedTech employers like Cook Medical (which manages 10% of its global manufacturing right here in Limerick), Johnson & Johnson Vision Care, BD, and Stryker provide a stable, high-value employment base.
Clare: Driving diagnostics and advanced therapies
Just across the border, Clare has carved out a highly specialised niche in diagnostics, respiratory technology, and emerging treatments. Beckman Coulter remains a central pillar in the county, employing 600 people and recently completing a €10 million expansion in 2024.
Clare is also making impressive strides into Advanced Therapy Medicinal Products (ATMPs), next-generation treatments like cell and gene therapies. Companies like MeiraGTx are leading this charge with viral vector manufacturing, while Vitalograph and Zimmer Biomet continue to drive respiratory and orthopaedic innovation.
Tipperary: Fusing pharma with the bioeconomy
Tipperary successfully balances traditional pharmaceutical manufacturing with pioneering initiatives in the circular economy. Boston Scientific employs over 1,000 people in Clonmel to manufacture pacemakers and defibrillators, while Amneal Pharmaceuticals operates a massive 200,000 sq ft facility in Cashel dedicated to inhaler production. Furthermore, MSD Ballydine remains a crucial site for creating active pharmaceutical ingredients, anchoring the county’s strong manufacturing heritage.
The infrastructure fueling our growth
Our regional success relies heavily on a “Triple Helix” model—a strong, continuous collaboration between universities, industry leaders, and government bodies. This ecosystem provides businesses with the practical tools and actionable insights they need to innovate.
- Manufacturing and Innovation Hubs: New facilities are embracing digital transformation. To assist companies in upgrading their operations, the government-supported Digital Manufacturing Ireland (DMI) is based in the National Technological Park, offering practical pathways for digital integration.
- Research and University Partnerships: The Bernal Institute at the University of Limerick (UL) acts as a major hub for process engineering, successfully nurturing local spin-outs like Cala Medical. UL also hosts the Confirm Centre, which focuses entirely on smart manufacturing and artificial intelligence.
- Bioeconomy Infrastructure: Tipperary is home to the National Bioeconomy Campus at Lisheen. This vital facility bridges the gap between laboratory research and commercialisation, helping businesses convert agri-food residues into high-value biochemicals.
- Healthcare Facilities: A strong clinical ecosystem supports this industrial growth, backed by University Hospital Limerick, Tipperary University Hospital, and upcoming private investments like the Bon Secours Hospital opening in Limerick in 2025.
Empowering our workforce for the future
The rapid shift toward digitalisation and advanced therapies has created intense competition for talent. For HR professionals and business leaders, understanding these skills gaps is essential for planning your future workforce.
Currently, the market urgently needs specialists in Manufacturing Execution Systems (MES), automation, bioprocessing, and AI data analysis. Additionally, new Corporate Sustainability Reporting Directive (CSRD) rules are driving a massive demand for experts in emissions reporting and energy efficiency.
Fortunately, our region provides tangible upskilling programmes to meet these demands:
- The iBio Programme: A unique partnership between UL, Eli Lilly, and Analog Devices designed to train the next generation of biotech leaders.
- UL@Work: Offers flexible, industry-designed programmes in AI and Data Analytics, allowing your staff to upskill while working.
- Corporate Training Centres: Companies like Stryker have established dedicated training facilities in Limerick to focus on automation and digital innovation.
By taking advantage of these regional hubs, you can equip your team with the expertise required to stay competitive.
Economic impact and supply chain innovation
The economic significance of the life sciences sector to the Midwest is staggering. Industry now accounts for 40.9% of our region’s Gross Value Added (GVA), making it the second-highest industrial concentration in Ireland.
Nationally, pharma exports reached an unprecedented €139 billion recently, driven largely by the global demand for GLP-1 hormone-based drugs used for diabetes and obesity treatments. Irish exports of hormone-related components to the US have nearly quadrupled, highlighting a massive opportunity for local supply chain partners.
To support this export boom, the Midwest leverages unique logistical assets to maintain global connectivity. Efficient logistics are critical for temperature-sensitive medical devices and biologics.
- Aviation: In October 2025, Shannon Airport will launch the world’s first fully dedicated life sciences air route to Wilmington, North Carolina. Operated by Boeing freighters, this temperature-controlled corridor features US customs pre-clearance and is designed specifically to protect cold-chain integrity.
- Specialised Logistics: Local operators such as Limerick Pharma Logistics, FreightSpeed, and HANNON PharmaLink provide dedicated road and cold-chain distribution networks, seamlessly linking the Midwest to mainland Europe and the UK.
Navigating challenges to unlock new opportunities
Growth always brings growing pains. To maintain our competitive edge, we must acknowledge and address regional bottlenecks.
The most critical barrier to expansion right now is housing. Ireland’s housing stock sits roughly 250,000 units below the European average per capita, making it difficult to attract and retain top talent. Furthermore, utility constraints present a hurdle for energy-intensive manufacturing, with both ESB Networks and Uisce Éireann flagging capacity limits. Navigating the regulatory complexity of overlapping agencies can also slow down necessary infrastructure development.
Despite these challenges, the future holds immense promise for businesses willing to adapt.
- Advanced Therapies (ATMPs): The shift toward personalised cell and mRNA therapies makes our existing high-value manufacturing base a prime candidate for future investment.
- The Circular Bioeconomy: With corporate sustainability mandates tightening, the National Bioeconomy Campus in Tipperary gives local industries a competitive advantage in producing sustainable materials.
- SME Integration: There is a massive opportunity for indigenous SMEs to integrate into multinational supply chains. Connecting with local clusters like IDEAM presents a clear avenue for localised economic growth and partnership.
Your next steps in the Midwest ecosystem
The Midwest of Ireland is a highly sophisticated, globally competitive life sciences hub. By effectively utilising our academic assets, proactive regulatory bodies (like the HPRA’s early dialogue models), and pioneering supply chain networks, our region continues to secure its place on the world stage.
For Chamber members, the growth of this sector is an invitation to innovate. Look closely at your own business model and ask how you can support this expanding ecosystem. Can you provide specialised logistics, sustainable materials, construction services, or data analysis?
Engage with regional upskilling programmes, connect with local innovation hubs, and explore how your team can help solve the challenges of tomorrow. By taking practical steps today, you can position your business to thrive alongside one of the most dynamic industries in the world.
